Spadrot M 80mg/250mg Tablet
Marketer
Deys Medical
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Spadrot M 80mg/250mg Tablet
Avelox-M 80mg/250mg tablets combine medications to alleviate abdominal pain. This formulation effectively diminishes abdominal pain, distension, discomfort, and spasms by relaxing gastrointestinal muscles and inhibiting pain-inducing neurotransmitters. Avelox-M 80mg/250mg tablets should be taken with meals, following your physician's prescribed dosage and regimen. Dosage is individualized based on your condition and response. Continue treatment as directed; premature cessation may lead to symptom recurrence and worsening condition. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach ache, dry mouth, appetite loss, thirst, and heartburn. These are often transient and self-limiting. Report any concerning side effects immediately to your doctor. Dizziness and drowsiness may occur; avoid driving or activities demanding alertness until the effects are known. Alcohol should be avoided due to potential dizziness exacerbation. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding before commencing treatment. Disclose any kidney or liver conditions to ensure appropriate dosage adjustments.
Primary Ingredients of Spadrot M 80mg/250mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Spadrot M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Spadrot M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Spadrot M 80mg/250mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Spadrot M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Spadrot M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Spadrot M 80mg/250mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.
How Spadrot M 80mg/250mg Tablet works:
Combiflam MD 80mg/250mg tablets combine drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, reducing painful contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of inflammatory mediators responsible for abdominal pain and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Spadrot M 80mg/250mg Tablet ingestion is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Spadrot M 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Spadrot M 80mg/250mg tablets while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Taking Spadrot M 80mg/250mg tablets might lead to adverse reactions that impair driving ability, as dizziness is a possible side effect.
KidneyCAUTION
Patients with impaired kidney function should use Spadrot M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Spadrot M 80mg/250mg tablets are contraindicated in individuals with severely compromised renal function.
LiverCAUTION
Patients with liver impairment should use Spadrot M 80mg/250mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Spadrot M 80mg/250mg Tablet :
Should you forget a Spadrot M 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Spadrot M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal System |
3,018 People bought this recently